<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Green Tea Hp &#187; egcg</title>
	<atom:link href="http://www.greenteahp.info/tag/egcg/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.greenteahp.info</link>
	<description>Instant Green Tea Supplement for Health and Weight Loss</description>
	<lastBuildDate>Fri, 25 Jun 2010 22:04:58 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>EGCG from Green Tea and General Health</title>
		<link>http://www.greenteahp.info/2009/10/egcg-from-green-tea-and-general-health/</link>
		<comments>http://www.greenteahp.info/2009/10/egcg-from-green-tea-and-general-health/#comments</comments>
		<pubDate>Mon, 19 Oct 2009 19:52:12 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Weight Loss]]></category>
		<category><![CDATA[cohort studies]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[egcg amounts]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[green tea studies]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=48</guid>
		<description><![CDATA[ 
Tea Catechins and Polyphenols: Health Effects,Metabolism, and Antioxidant Functions


 



Jane V. Higdon and Balz Frei*Linus Pauling Institute, Oregon State University, Corvallis, OR 97331
 ABSTRACT: Increasing interest in the health benefits of tea has led to the inclusion of tea extracts in dietary supplements and functional foods. However, epidemiologic evidence regarding the effects of tea consumption on cancer [...]]]></description>
			<content:encoded><![CDATA[<p align="left"> </p>
<div><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"><span style="color: #000000;"><span style="font-size: small;">Tea Catechins and Polyphenols: Health Effects,Metabolism, and Antioxidant Functions</span></span></span></span></div>
<p><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"></p>
<div></div>
<p> </p>
<p></span></span></p>
<div><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"></span></span></span></div>
<p><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; mso-layout-grid-align: none;"><span style="color: #000000;"><span style="font-size: small;">Jane V. Higdon and Balz Frei*Linus Pauling Institute, Oregon State University, Corvallis, OR 97331</span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0pt; mso-layout-grid-align: none;"><span style="color: #000000;"><span style="font-size: small;"> </span></span><span style="font-size: small;"><span style="color: #000000;">ABSTRACT: </span><span style="color: #000000;">Increasing interest in the health benefits of tea has led to the inclusion of tea extracts in dietary supplements and functional foods. However, epidemiologic evidence regarding the effects of tea consumption on cancer and cardiovascular disease risk is conflicting. While tea contains a number of bioactive chemicals, it is </span></span><span style="color: #000000;"><span style="font-size: small;">particularly rich in catechins, of which epigallocatechin gallate (EGCG) is the most abundant. Catechins and their derivatives are thought to contribute to the beneficial effects ascribed to tea. Tea catechins and polyphenols are effective scavengers of reactive oxygen species <em>in vitro </em>and may also function indirectly as antioxidants through </span></span><span style="color: #000000;"><span style="font-size: small;">their effects on transcription factors and enzyme activities. The fact that catechins are rapidly and extensively metabolized emphasizes the importance of demonstrating their antioxidant activity <em>in vivo</em>. In humans, modest transient increases in plasma antioxidant capacity have been demonstrated following the consumption of tea and </span></span><span style="color: #000000;"><span style="font-size: small;">green tea catechins. The effects of tea and green tea catechins on biomarkers of oxidative stress, especially oxidative DNA damage, appear very promising in animal models, but data on biomarkers of <em>in vivo </em>oxidative stress in humans are limited. Larger human studies examining the effects of tea and tea catechin intake on biomarkers </span></span><span style="color: #000000;"><span style="font-size: small;">of oxidative damage to lipids, proteins, and DNA are needed.<span style="mso-spacerun: yes;">  </span></span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 10pt;"><span style="color: #000000;"><span style="font-size: small;"><span style="mso-spacerun: yes;">&#8220;<em>This study was a compilation of about one-hundred different studies that have investigated the general health benefits of EGCG from green tea.  The amount of data compiled from all these sources have indicated a benefit when consuming 100-200 mg EGCG per day and even more benefit to consuming 400 mg EGCG per day.  Getting the right amount is paramount to the benefits for general health.&#8221; &#8211; Josh Smith</em></span></span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 10pt;"> </p>
<div></div>
<div><span style="font-size: large; font-family: Arial;"></span></div>
<p><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"></p>
<p align="left"> </p>
<p> </p>
<p> </p>
<p></span></span></p>
<div></div>
<p></span><span style="font-size: large; font-family: Arial;"></p>
<p align="left"> </p>
<p> </p>
<div></div>
<div><span style="font-size: large; font-family: Arial;"></span></div>
<p></span></span></span><span style="font-size: large; font-family: Arial;"><span style="font-size: large; font-family: Arial;"></p>
<p align="left"> </p>
<p> </p>
<p> </p>
<p> </p>
<p></span> </p>
<p></span></span></p>
<p> </p>
<p align="left"> </p>
<p align="left"> </p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/10/egcg-from-green-tea-and-general-health/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Medicinal benefits of green tea</title>
		<link>http://www.greenteahp.info/2009/10/medicinal-benefits-of-green-tea/</link>
		<comments>http://www.greenteahp.info/2009/10/medicinal-benefits-of-green-tea/#comments</comments>
		<pubDate>Thu, 15 Oct 2009 20:39:37 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Weight Loss]]></category>
		<category><![CDATA[cardiovascular  health]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[green tea extract]]></category>
		<category><![CDATA[HDL]]></category>
		<category><![CDATA[LDL]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=47</guid>
		<description><![CDATA[
 

THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINEVolume 11, Number 3, 2005, pp. 521–528
Medicinal Benefits of Green Tea: Part I.
Review of Noncancer Health Benefits
RAYMOND COOPER, Ph.D.,1 D. JAMES MORRÉ, Ph.D.,2 and DOROTHY M. MORRÉ, Ph.D.
 ABSTRACT
Tea, in the form of green or black tea, is one of the most widely consumed beverages in the world. Extracts of [...]]]></description>
			<content:encoded><![CDATA[<p><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"></span></p>
<p align="left"> </p>
<p><span style="font-size: small; color: #231f20; font-family: Times-Bold;"></span></p>
<p align="left"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: 7.5pt; color: #231f20;"><strong>THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE</strong></span><span style="font-size: 7.5pt; color: #231f20;"><strong>Volume 11, Number 3, 2005, pp. 521–528</strong></span></p>
<p><span style="font-size: 18pt; color: #231f20;">Medicinal Benefits of Green Tea: Part I.</span></p>
<p><span style="font-size: 18pt; color: #231f20;">Review of Noncancer Health Benefits</span></p>
<p><span style="color: #231f20;"><span style="font-size: small;">RAYMOND COOPER, Ph.D.,</span></span><span style="font-size: 7.5pt; color: #231f20;">1 </span><span style="color: #231f20;"><span style="font-size: small;">D. JAMES MORRÉ, Ph.D.,</span></span><span style="font-size: 7.5pt; color: #231f20;">2 </span><span style="font-size: small;"><span style="color: #231f20;">and DOROTHY M. MORRÉ, Ph.D.</span></span></p>
<p><span style="font-size: 7.5pt; color: #231f20;"> </span><span style="color: #231f20;"><strong><span style="font-size: small;">ABSTRACT</span></strong></span></p>
<p><span style="color: #231f20;"><span style="font-size: small;">Tea, in the form of green or black tea, is one of the most widely consumed beverages in the world. Extracts of tea leaves also are sold as dietary supplements. However, with the increasing interest in the health properties of tea and a significant rise in scientific investigation, this review covers recent findings on the medicinal properties and noncancer health benefits of both green and black tea. In Part II, a review of anticancer properties of green tea extracts is presented. Green tea contains a unique set of catechins that possess biological activity in antioxidant, anti-angiogenesis, and antiproliferative assays potentially relevant to the prevention and treatment of various forms of cancer. Although there has been much focus on the biological properties of the major tea catechin epigallocatechin gallate (EGCg) and its antitumor properties, tea offers other health benefits; some due to the presence of other important constituents. Characteristics unrelated to the antioxidant properties of green and black teas may be responsible for tea’s anticancer activity and improvement in cardiac health and atherosclerosis. Theanine in green tea may play a role in reducing stress. Oxidized catechins (theaflavins in black tea) may reduce cholesterol levels in blood. Synergistic properties of green tea extracts with other sources of polyphenolic constituents are increasingly recognized as being potentially important to the medicinal benefits of black and green teas.</span></span></p>
<p><span style="color: #231f20;"><em><span style="font-size: small;">&#8220;Increasing cardiovascular health, recuding stress levels and improving weight loss were the main questions tackled in this article.  Regular consmption of green tea extract helps improve cholesterol levels as well.  These benefits are achieved through long term use of green tea!&#8221;  &#8211; Josh Smith</span></em></span></p>
<p><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"> </span></span></span></p>
<p><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><font face="Times-Bold" size="1" color="#231f20"><font face="Times-Bold" size="1" color="#231f20"><font face="Times-Bold" size="1" color="#231f20"> </p>
<p></font></font></font></span></span><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><font face="Times-Bold" size="1" color="#231f20"><font face="Times-Bold" size="1" color="#231f20"> </p>
<p></font></font></span></span><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><font face="Times-Bold" size="1" color="#231f20"> </p>
<p></font></span></span> </p>
<p></span></span><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"> </span></span></p>
<p><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><font face="Times-Bold" size="1" color="#231f20"><font face="Times-Bold" size="1" color="#231f20"> </p>
<p></font></font></span></span><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><font face="Times-Bold" size="1" color="#231f20"> </p>
<p></font></span></span> </p>
<p></span></span><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"> </span></p>
<p><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><span style="font-size: xx-small; color: #231f20; font-family: Times-Bold;"><font face="Times-Bold" size="1" color="#231f20"> </p>
<p></font></span></span> </p>
<p></span></span></p>
<p> </p>
<p align="left"><span style="font-size: small; color: #231f20; font-family: Times-Roman;"></span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/10/medicinal-benefits-of-green-tea/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>green tea consumption and chronic disease</title>
		<link>http://www.greenteahp.info/2009/10/green-tea-consumption-and-chronic-disease/</link>
		<comments>http://www.greenteahp.info/2009/10/green-tea-consumption-and-chronic-disease/#comments</comments>
		<pubDate>Wed, 14 Oct 2009 17:57:30 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Weight Loss]]></category>
		<category><![CDATA[cardiovascualr disease]]></category>
		<category><![CDATA[chronic disease]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[green tea consumpion]]></category>
		<category><![CDATA[stroke]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=46</guid>
		<description><![CDATA[ &#60;!&#8211;  /* Font Definitions */  @font-face 	{font-family:&#8221;Cambria Math&#8221;; 	panose-1:0 0 0 0 0 0 0 0 0 0; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style [...]]]></description>
			<content:encoded><![CDATA[<p><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF /> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> <w:SplitPgBreakAndParaMark /> <w:DontVertAlignCellWithSp /> <w:DontBreakConstrainedForcedTables /> <w:DontVertAlignInTxbx /> <w:Word11KerningPairs /> <w:CachedColBalance /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math" /> <m:brkBin m:val="before" /> <m:brkBinSub m:val="&#45;-" /> <m:smallFrac m:val="off" /> <m:dispDef /> <m:lMargin m:val="0" /> <m:rMargin m:val="0" /> <m:defJc m:val="centerGroup" /> <m:wrapIndent m:val="1440" /> <m:intLim m:val="subSup" /> <m:naryLim m:val="undOvr" /> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal" /> <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /> <w:LsdException Locked="false" Priority="39" Name="toc 1" /> <w:LsdException Locked="false" Priority="39" Name="toc 2" /> <w:LsdException Locked="false" Priority="39" Name="toc 3" /> <w:LsdException Locked="false" Priority="39" Name="toc 4" /> <w:LsdException Locked="false" Priority="39" Name="toc 5" /> <w:LsdException Locked="false" Priority="39" Name="toc 6" /> <w:LsdException Locked="false" Priority="39" Name="toc 7" /> <w:LsdException Locked="false" Priority="39" Name="toc 8" /> <w:LsdException Locked="false" Priority="39" Name="toc 9" /> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /> <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title" /> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /> <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /> <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong" /> <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /> <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /> <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /> <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /> <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote" /> <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6" /> <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" /> <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" /> <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" /> <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" /> <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title" /> <w:LsdException Locked="false" Priority="37" Name="Bibliography" /> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" /> </w:LatentStyles> </xml><![endif]--> &lt;!&#8211;  /* Font Definitions */  @font-face 	{font-family:&#8221;Cambria Math&#8221;; 	panose-1:0 0 0 0 0 0 0 0 0 0; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:&#8221;"; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	mso-bidi-font-size:11.0pt; 	font-family:&#8221;Times New Roman&#8221;,&#8221;serif&#8221;; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-bidi-font-family:&#8221;Times New Roman&#8221;; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:12.0pt; 	mso-ansi-font-size:12.0pt; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-bidi-font-family:&#8221;Times New Roman&#8221;; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.0in 1.0in 1.0in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} &#8211;&gt; <!--[if gte mso 10]></p>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
</style>
<p><![endif]--></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td style="padding: 0in;">
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><strong><span>Green Tea Consumption and Mortality   among Japanese Elderly People: The Prospective Shizuoka Elderly Cohort. </span></strong></p>
<p class="MsoNormal" style="margin-bottom: 0.0001pt;">
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><strong><span>Author: </span></strong><span><a title="Find all records containing" href="http://primofe1.byu.edu/primo_library/libweb/action/search.do?vl%28freeText0%29=Suzuki%2c+Etsuji+etsuji-s%40cc.okayama-u.ac.jp&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;fn=search&amp;tab=remote&amp;mode=Basic&amp;vid=byu-cl&amp;scp.scps=000000200" onclick="javascript:pageTracker._trackPageview('/outbound/article/primofe1.byu.edu');" target="_parent"><span style="text-decoration: none; color: #000000;">Suzuki, Etsuji </span></a>; <a title="Find all records containing" href="http://primofe1.byu.edu/primo_library/libweb/action/search.do?vl%28freeText0%29=+Yorifuji%2c+Takashi&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;vl%28freeText0%29=Suzuki%2c+Etsuji+etsuji-s%40cc.okayama-u.ac.jp&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;fn=search&amp;tab=remote&amp;mode=Basic&amp;vid=byu-cl&amp;scp.scps=000000200" onclick="javascript:pageTracker._trackPageview('/outbound/article/primofe1.byu.edu');" target="_parent"><span style="text-decoration: none; color: #000000;">Yorifuji, Takashi</span></a> ; <a title="Find all records containing" href="http://primofe1.byu.edu/primo_library/libweb/action/search.do?vl%28freeText0%29=+Takao%2c+Soshi&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;vl%28freeText0%29=+Yorifuji%2c+Takashi&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;vl%28freeText0%29=Suzuki%2c+Etsuji+etsuji-s%40cc.okayama-u.ac.jp&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;fn=search&amp;tab=remote&amp;mode=Basic&amp;vid=byu-cl&amp;scp.scps=000000200" onclick="javascript:pageTracker._trackPageview('/outbound/article/primofe1.byu.edu');" target="_parent"><span style="text-decoration: none; color: #000000;">Takao, Soshi</span></a> ; et al. Annals of Epidemiology Oct2009, Vol. 19 Issue 10, p732-739 8p<br />
<!--[endif]--></span></p>
<p class="MsoNormal"><strong><span>Description: </span></strong><span>Purpose: To investigate the association between green tea consumption and mortality from all causes, cancer, and cardiovascular disease (CVD) among elderly people. Methods: In a population-based, prospective cohort study, a total of 14,001 elderly residents (aged 65-84 years), randomly chosen from all 74 municipalities in Shizuoka, Japan, completed questionnaires that included items about frequency of green tea consumption. They were followed for up to 6 years, from December 1999 to March 2006. Consequently, 12,251 subjects were analyzed to estimate the hazard ratios (HRs) for all-cause mortality, cancer, and CVD. Results: Among 64,002 person-years, 1,224 deaths were identified (follow-up rate, 71.6%). The multivariate HRs and 95% confidence intervals (CIs) for CVD mortality compared those who consumed seven or more cups per day with those who consumed less than one cup per day, were 0.24 (0.14-0.40), 0.30 (0.15-0.61), and 0.18 (0.08-0.40) for total participants, men, and women, respectively. Although green tea consumption was not inversely associated with cancer mortality, green tea consumption and colorectal cancer mortality were inversely associated with a moderate dose-response relationship. Conclusions: Green tea consumption is associated with reduced mortality from all causes and CVD. This study also suggests that green tea could have protective effects against colorectal cancer. </span></p>
<p class="MsoNormal">
<p class="MsoNormal"><em>&#8220;The conclusions from this study are bold and quite powerful!  Those who consumed 7 or more cups of fresh green tea per day had a significant decrease in the amount of all cause mortality (stroke, cancer, heart disease, hypertension, and diabetes) and cardiovascular disease.  This study followed about 13,636 people for 6 years to obtain this information.  Regular consumption of green tea has short-term and long-term health benefits.&#8221;  &#8211; Josh Smith</em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/10/green-tea-consumption-and-chronic-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>green tea and weight loss among obese</title>
		<link>http://www.greenteahp.info/2009/10/green-tea-and-weight-loss-among-obese/</link>
		<comments>http://www.greenteahp.info/2009/10/green-tea-and-weight-loss-among-obese/#comments</comments>
		<pubDate>Wed, 14 Oct 2009 17:36:50 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Weight Loss]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[food intake]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[thermogenics]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=45</guid>
		<description><![CDATA[&#60;!&#8211;  /* Font Definitions */  @font-face 	{font-family:&#8221;Cambria Math&#8221;; 	panose-1:0 0 0 0 0 0 0 0 0 0; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions [...]]]></description>
			<content:encoded><![CDATA[<p><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves /> <w:TrackFormatting /> <w:PunctuationKerning /> <w:ValidateAgainstSchemas /> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF /> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables /> <w:SnapToGridInCell /> <w:WrapTextWithPunct /> <w:UseAsianBreakRules /> <w:DontGrowAutofit /> <w:SplitPgBreakAndParaMark /> <w:DontVertAlignCellWithSp /> <w:DontBreakConstrainedForcedTables /> <w:DontVertAlignInTxbx /> <w:Word11KerningPairs /> <w:CachedColBalance /> </w:Compatibility> <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel> <m:mathPr> <m:mathFont m:val="Cambria Math" /> <m:brkBin m:val="before" /> <m:brkBinSub m:val="&#45;-" /> <m:smallFrac m:val="off" /> <m:dispDef /> <m:lMargin m:val="0" /> <m:rMargin m:val="0" /> <m:defJc m:val="centerGroup" /> <m:wrapIndent m:val="1440" /> <m:intLim m:val="subSup" /> <m:naryLim m:val="undOvr" /> </m:mathPr></w:WordDocument> </xml><![endif]--><!--[if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"   DefSemiHidden="true" DefQFormat="false" DefPriority="99"   LatentStyleCount="267"> <w:LsdException Locked="false" Priority="0" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Normal" /> <w:LsdException Locked="false" Priority="9" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="heading 1" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /> <w:LsdException Locked="false" Priority="39" Name="toc 1" /> <w:LsdException Locked="false" Priority="39" Name="toc 2" /> <w:LsdException Locked="false" Priority="39" Name="toc 3" /> <w:LsdException Locked="false" Priority="39" Name="toc 4" /> <w:LsdException Locked="false" Priority="39" Name="toc 5" /> <w:LsdException Locked="false" Priority="39" Name="toc 6" /> <w:LsdException Locked="false" Priority="39" Name="toc 7" /> <w:LsdException Locked="false" Priority="39" Name="toc 8" /> <w:LsdException Locked="false" Priority="39" Name="toc 9" /> <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /> <w:LsdException Locked="false" Priority="10" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Title" /> <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /> <w:LsdException Locked="false" Priority="11" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /> <w:LsdException Locked="false" Priority="22" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Strong" /> <w:LsdException Locked="false" Priority="20" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /> <w:LsdException Locked="false" Priority="59" SemiHidden="false"    UnhideWhenUsed="false" Name="Table Grid" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /> <w:LsdException Locked="false" Priority="1" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 1" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 1" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 1" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /> <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /> <w:LsdException Locked="false" Priority="34" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /> <w:LsdException Locked="false" Priority="29" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Quote" /> <w:LsdException Locked="false" Priority="30" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 1" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 1" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 2" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 2" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 2" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 2" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 2" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 3" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 3" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 3" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 3" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 3" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 4" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 4" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 4" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 4" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 4" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 5" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 5" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 5" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 5" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 5" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /> <w:LsdException Locked="false" Priority="60" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Shading Accent 6" /> <w:LsdException Locked="false" Priority="61" SemiHidden="false"    UnhideWhenUsed="false" Name="Light List Accent 6" /> <w:LsdException Locked="false" Priority="62" SemiHidden="false"    UnhideWhenUsed="false" Name="Light Grid Accent 6" /> <w:LsdException Locked="false" Priority="63" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /> <w:LsdException Locked="false" Priority="64" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /> <w:LsdException Locked="false" Priority="65" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /> <w:LsdException Locked="false" Priority="66" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /> <w:LsdException Locked="false" Priority="67" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /> <w:LsdException Locked="false" Priority="68" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /> <w:LsdException Locked="false" Priority="69" SemiHidden="false"    UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" /> <w:LsdException Locked="false" Priority="70" SemiHidden="false"    UnhideWhenUsed="false" Name="Dark List Accent 6" /> <w:LsdException Locked="false" Priority="71" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Shading Accent 6" /> <w:LsdException Locked="false" Priority="72" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful List Accent 6" /> <w:LsdException Locked="false" Priority="73" SemiHidden="false"    UnhideWhenUsed="false" Name="Colorful Grid Accent 6" /> <w:LsdException Locked="false" Priority="19" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" /> <w:LsdException Locked="false" Priority="21" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" /> <w:LsdException Locked="false" Priority="31" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" /> <w:LsdException Locked="false" Priority="32" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" /> <w:LsdException Locked="false" Priority="33" SemiHidden="false"    UnhideWhenUsed="false" QFormat="true" Name="Book Title" /> <w:LsdException Locked="false" Priority="37" Name="Bibliography" /> <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" /> </w:LatentStyles> </xml><![endif]-->&lt;!&#8211;  /* Font Definitions */  @font-face 	{font-family:&#8221;Cambria Math&#8221;; 	panose-1:0 0 0 0 0 0 0 0 0 0; 	mso-font-charset:1; 	mso-generic-font-family:roman; 	mso-font-format:other; 	mso-font-pitch:variable; 	mso-font-signature:0 0 0 0 0 0;} @font-face 	{font-family:Calibri; 	panose-1:2 15 5 2 2 2 4 3 2 4; 	mso-font-charset:0; 	mso-generic-font-family:swiss; 	mso-font-pitch:variable; 	mso-font-signature:-1610611985 1073750139 0 0 159 0;}  /* Style Definitions */  p.MsoNormal, li.MsoNormal, div.MsoNormal 	{mso-style-unhide:no; 	mso-style-qformat:yes; 	mso-style-parent:&#8221;"; 	margin-top:0in; 	margin-right:0in; 	margin-bottom:10.0pt; 	margin-left:0in; 	mso-pagination:widow-orphan; 	font-size:12.0pt; 	mso-bidi-font-size:11.0pt; 	font-family:&#8221;Times New Roman&#8221;,&#8221;serif&#8221;; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-bidi-font-family:&#8221;Times New Roman&#8221;; 	mso-bidi-theme-font:minor-bidi;} .MsoChpDefault 	{mso-style-type:export-only; 	mso-default-props:yes; 	font-size:12.0pt; 	mso-ansi-font-size:12.0pt; 	mso-fareast-font-family:Calibri; 	mso-fareast-theme-font:minor-latin; 	mso-bidi-font-family:&#8221;Times New Roman&#8221;; 	mso-bidi-theme-font:minor-bidi;} .MsoPapDefault 	{mso-style-type:export-only; 	margin-bottom:10.0pt;} @page Section1 	{size:8.5in 11.0in; 	margin:1.0in 1.0in 1.0in 1.0in; 	mso-header-margin:.5in; 	mso-footer-margin:.5in; 	mso-paper-source:0;} div.Section1 	{page:Section1;} &#8211;&gt;</p>
<p><!--[if gte mso 10]></p>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
</style>
<p><![endif]--></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td style="padding: 0in;">
<p class="MsoNormal" style="margin-bottom: 0.0001pt;"><span><strong>Effectiveness   of green tea on weight reduction in obese Thais: A randomized, controlled   trial</strong> </span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span>PHYSIOLOGY &amp; BEHAVIOR 93 (3): 486-491 FEB 27 2008 <span>Author: </span><a title="Find all records containing" href="http://primofe1.byu.edu/primo_library/libweb/action/search.do?vl%28freeText0%29=Auvichayapat%2c+P&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;fn=search&amp;tab=remote&amp;mode=Basic&amp;vid=byu-cl&amp;scp.scps=000000200" onclick="javascript:pageTracker._trackPageview('/outbound/article/primofe1.byu.edu');" target="_parent"><span style="text-decoration: none; color: #000000;">Auvichayapat, P</span></a> ; <a title="Find all records containing" href="http://primofe1.byu.edu/primo_library/libweb/action/search.do?vl%28freeText0%29=Prapochanung%2c+M&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;fn=search&amp;tab=remote&amp;mode=Basic&amp;vid=byu-cl&amp;scp.scps=000000200" onclick="javascript:pageTracker._trackPageview('/outbound/article/primofe1.byu.edu');" target="_parent"><span style="text-decoration: none; color: #000000;">Prapochanung, M</span></a> ; <a title="Find all records containing" href="http://primofe1.byu.edu/primo_library/libweb/action/search.do?vl%28freeText0%29=+Tunkarnnerdthai%2c+O&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;vl%28freeText0%29=Prapochanung%2c+M&amp;vl%2813550901UI0%29=creator&amp;vl%2815993830UI1%29=all_items&amp;fn=search&amp;tab=remote&amp;mode=Basic&amp;vid=byu-cl&amp;scp.scps=000000200" onclick="javascript:pageTracker._trackPageview('/outbound/article/primofe1.byu.edu');" target="_parent"><span style="text-decoration: none; color: #000000;">Tunkarnnerdthai, O</span></a> et al.</span></p>
<p><span style="font-size: 12pt; font-family: ">Description: </span><span style="font-size: 12pt; font-family: ">This study was undertaken to investigate the effects of green tea on weight reduction in obese Thais.;A randomized, controlled trial involving 60 obese subjects (body mass index, BMI &gt; 25kg/m(2)) was conducted. All subjects consumed a Thai diet containing 3 meals (8373.6kJ/day) for 12weeks, prepared by the Nutritional Unit at Srinagarind Hospital. The diet contained 65% carbohydrates, 15% protein, and 20% fat. Body weight, BMI, body composition, resting energy expenditure, and substrate oxidation were measured at baseline, and during weeks 4, 8, and 12 of the study. Serum levels of leptin and urine VMA were measured at baseline and during the 12th week. Differences over time and between the treatments (green tea or placebo) over time were determined using two-factor ANOVA with repeated measures.;In comparing the two groups, differences in weight loss were 2.70, 5.10, and 3.3kg during the 4th, 8th, and 12th weeks of the study, respectively. At the 8th and 12th weeks of the study, body weight loss was significantly different (P &lt; 0.05). At the 8th week, the difference in resting energy expenditure was 183.38kJ/day (P &lt; 0.001), the difference in the respiratory quotient was 0.02 (P &lt; 0.05), and no significant differences existed in satiety score, food intake, or physical activity. Urine VMA was significantly different in the 12th week of the study (P &lt; 0.05).;We conclude that green tea can reduce body weight in obese Thai subjects by increasing energy expenditure and fat oxidation.</span></p>
<p><em>&#8220;The findings of this study among obese Thai subjects found that daily consumption of green tea extract increased the amount of calories burned at rest.  Another interesting finding in this particular study is the amount of weight loss for those who consumed green tea extract for 12 weeks.  The weight loss was 7.35 pounds greater than those who didn&#8217;t use green tea extract.&#8221;  &#8211; Josh Smith</em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/10/green-tea-and-weight-loss-among-obese/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Green Tea and Bone Metabolism</title>
		<link>http://www.greenteahp.info/2009/10/green-tea-and-bone-metabolism/</link>
		<comments>http://www.greenteahp.info/2009/10/green-tea-and-bone-metabolism/#comments</comments>
		<pubDate>Tue, 06 Oct 2009 22:09:59 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[bone density]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[oxidative stress]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=44</guid>
		<description><![CDATA[NUTRITION RESEARCH   Volume: 29   Issue: 7   Pages: 437-456   Published: JUL 2009; Shen CL, Yeh JK, Cao JJ, et al.
Abstract: Osteoporosis is a major health problem in both elderly women and men. Epidemiological evidence has shown an association between tea consumption and the prevention of age-related bone loss in elderly women and men. Ingestion of green [...]]]></description>
			<content:encoded><![CDATA[<p><span class="data_bold"><strong>NUTRITION RESEARCH</strong></span>   Volume: <span class="data_bold"><strong>29</strong></span>   Issue: <span class="data_bold"><strong>7</strong></span>   Pages: <span class="data_bold"><strong>437-456</strong></span>   Published: <span class="data_bold"><strong>JUL 2009; </strong>Shen CL, Yeh JK, Cao JJ, et al.</span></p>
<p><span class="FR_label"><strong>Abstract:</strong></span> Osteoporosis is a major health problem in both elderly women and men. Epidemiological evidence has shown an association between <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> consumption and the prevention of age-related bone loss in elderly women and men. Ingestion of <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> and <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> bioactive compounds may be beneficial in mitigating bone loss of this population and decreasing their risk of osteoporotic fractures. This review describes the effect of <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> or its bioactive components on bone health, with an emphasis on (i) the prevalence and etiology of osteoporosis; (ii) the role of oxidative stress and antioxidants in osteoporosis; (iii) <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> composition and bioavailability; (iv) the effects of <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> and its active components on osteogenesis, osteoblastogenesis, and osteoclastogenesis from human epidemiological, animal, as well as cell culture studies; (v) possible mechanisms explaining the osteoprotective effects of <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> bioactive compounds; (vi) other bioactive components in <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> that benefit bone health; and (vii) a summary and future direction of <span class="hitHilite"><span style="background-color: #fff3c6;">green</span></span> <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> and bone health research and the translational aspects. In general, <span class="hitHilite"><span style="background-color: #fff3c6;">tea</span></span> and its bioactive components might decrease the risk of fracture by improving bone mineral density and supporting ostcoblastic activities while suppressing osteoclastic activities.</p>
<p><em>&#8220;Osteoporosis is not limited to one gender.  Both genders are susceptible to losing bone mass as we age.  One great way to offset this process is <a href="http://www.grenx.com/ProductPage.aspx?ItemID=151" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">PINK</a> by <a href="http://www.grenx.com/RetailProductList.aspx" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">GreenTeaHP</a> which contains the necessary <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">EGCG</a> content along with l-carnitine both promote healthy bone mass.&#8221;   &#8211; Josh Smith</em></p>
<p> </p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/10/green-tea-and-bone-metabolism/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EGCG and Weight Loss</title>
		<link>http://www.greenteahp.info/2009/10/egcg-and-weight-loss/</link>
		<comments>http://www.greenteahp.info/2009/10/egcg-and-weight-loss/#comments</comments>
		<pubDate>Mon, 05 Oct 2009 19:27:18 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Body]]></category>
		<category><![CDATA[body fat]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[fatty liver disease]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[Josh Smith]]></category>
		<category><![CDATA[lipid absorption]]></category>
		<category><![CDATA[lipid accumulation]]></category>
		<category><![CDATA[Liver]]></category>
		<category><![CDATA[obese mice]]></category>
		<category><![CDATA[plasma cholesterol]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[visceral body fat]]></category>
		<category><![CDATA[weight]]></category>
		<category><![CDATA[Weight Loss]]></category>
		<category><![CDATA[weight reduction]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=42</guid>
		<description><![CDATA[The Major Green Tea Polyphenol, Epigallocatechin-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice.  Journal of Nutrition.  2008 September; 138(9): 1677-1683 
In this study, we investigated the effects of the major green tea polyphenol, (−)-epigallocatechin-3-gallate (EGCG), on high-fat–induced obesity, symptoms of the metabolic syndrome, and fatty liver in mice. In mice fed [...]]]></description>
			<content:encoded><![CDATA[<div class="p p-first-last"><strong>The Major Green Tea Polyphenol, Epigallocatechin-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice.</strong>  <em>Journal of Nutrition.  2008 September; 138(9): 1677-1683<sup><span class="citation-flpages"> </span></sup></em></div>
<div class="p p-first-last">In this study, we investigated the effects of the major green tea polyphenol, (−)-epigallocatechin-3-gallate (EGCG), on high-fat–induced obesity, symptoms of the metabolic syndrome, and fatty liver in mice. In mice fed a high-fat diet (60% energy as fat), supplementation with dietary EGCG treatment (3.2 g/kg diet) for 16 wk reduced body weight (BW) gain, percent body fat, and visceral fat weight (<em>P</em> &lt; 0.05) compared with mice without EGCG treatment. The BW decrease was associated with increased fecal lipids in the high-fat–fed groups (<em>r</em><sup>2</sup> = 0.521; <em>P</em> &lt; 0.05). EGCG treatment attenuated insulin resistance, plasma cholesterol, and monocyte chemoattractant protein concentrations in high-fat–fed mice (<em>P</em> &lt; 0.05). EGCG treatment also decreased liver weight, liver triglycerides, and plasma alanine aminotransferase concentrations in high-fat–fed mice (<em>P</em> &lt; 0.05). Histological analyses of liver samples revealed decreased lipid accumulation in hepatocytes in mice treated with EGCG compared with high-fat diet-fed mice without EGCG treatment. In another experiment, 3-mo-old high-fat–induced obese mice receiving short-term EGCG treatment (3.2 g/kg diet, 4 wk) had decreased mesenteric fat weight and blood glucose compared with high-fat–fed control mice (<em>P</em> &lt; 0.05). Our results indicate that long-term EGCG treatment attenuated the development of obesity, symptoms associated with the metabolic syndrome, and fatty liver. Short-term EGCG treatment appeared to reverse preexisting high-fat–induced metabolic pathologies in obese mice. These effects may be mediated by decreased lipid absorption, decreased inflammation, and other mechanisms.</div>
<div class="p p-first-last"><em>&#8220;The groups in this study were fed high fat diets that left them overweight and obese.  The solution was a mixture of <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">EGCGs</a>.  The short term results of introducing <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">EGCGs</a> into their diets was a reduction in body fat.  Not only a reduction in body fat, but a reduction in visceral body fat!  The best tasting and most convenient way to ge the necessary <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">EGCGs</a> is <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">GreenTeaHP</a> by grenx!&#8221;   &#8211; Josh Smith</em></div>
<div class="fm-title"><em></em></div>
<p> </p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/10/egcg-and-weight-loss/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>green tea, EGCG and weight loss</title>
		<link>http://www.greenteahp.info/2009/09/green-tea-egcg-and-weight-loss/</link>
		<comments>http://www.greenteahp.info/2009/09/green-tea-egcg-and-weight-loss/#comments</comments>
		<pubDate>Tue, 29 Sep 2009 01:41:37 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Weight Loss]]></category>
		<category><![CDATA[beauty tea]]></category>
		<category><![CDATA[catechins]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[muscle pump]]></category>
		<category><![CDATA[peach cream]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=41</guid>
		<description><![CDATA[Effects of Catechin Enriched Green Tea on Body Composition
Obesity (2009) doi:10.1038/oby.2009.256
Hongqiang Wang1, Yibo Wen1, Yaping Du1, Xiuyuan Yan1, Hongwei Guo2, Jane A. Rycroft3, Niels Boon4, Eva M.R. Kovacs4 and David J. Mela4 Received 30 October 2008; Accepted 2 July 2009; Published online 13 August 2009.
Obesity is a major health problem in the developed and developing world. Many &#8220;functional&#8221; foods and ingredients are advocated for their effects on body composition but [...]]]></description>
			<content:encoded><![CDATA[<p class="MsoNormal" style="line-height: normal; margin: 0in 0in 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-outline-level: 2;"><strong style="mso-bidi-font-weight: normal;"><span style="font-family: " lang="EN">Effects of Catechin Enriched Green Tea on Body Composition</span></strong></p>
<p class="MsoNormal" style="line-height: normal; margin: 0in 0in 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"><em><span style="font-family: " lang="EN">Obesity</span></em><span style="font-family: " lang="EN"> (2009) doi:10.1038/oby.2009.256</span></p>
<p class="MsoNormal" style="line-height: normal; margin: 0in 0in 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"><span style="font-family: " lang="EN">Hongqiang Wang<sup><a title="affiliated with 1" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff1" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">1</span></a></sup>, Yibo Wen<sup><a title="affiliated with 1" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff1" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">1</span></a></sup>, Yaping Du<sup><a title="affiliated with 1" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff1" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">1</span></a></sup>, Xiuyuan Yan<sup><a title="affiliated with 1" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff1" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">1</span></a></sup>, Hongwei Guo<sup><a title="affiliated with 2" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">2</span></a></sup>, Jane A. Rycroft<sup><a title="affiliated with 3" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff3" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">3</span></a></sup>, Niels Boon<sup><a title="affiliated with 4" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff4" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">4</span></a></sup>, Eva M.R. Kovacs<sup><a title="affiliated with 4" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff4" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">4</span></a></sup> and David J. Mela<sup><a title="affiliated with 4" href="http://www.nature.com/oby/journal/vaop/ncurrent/abs/oby2009256a.html#aff4" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.nature.com');"><span style="color: #3366cc;">4</span></a> </sup>Received 30 October 2008; Accepted 2 July 2009; Published online 13 August 2009.</span></p>
<p class="MsoNormal" style="line-height: normal; margin: 0in 0in 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"><span style="font-family: " lang="EN">Obesity is a major health problem in the developed and developing world. Many &#8220;functional&#8221; foods and ingredients are advocated for their effects on body composition but few have consistent scientific support for their efficacy. However, an increasing amount of mechanistic and clinical evidence is building for green tea (GT). This experiment was therefore undertaken to study the effects of a high-catechin GT on body composition in a moderately overweight Chinese population. In a randomized placebo-controlled trial, 182 moderately overweight Chinese subjects, consumed either two servings of a control drink (C; 30 mg catechins, 10 mg caffeine/day), one serving of the control drink and one serving of an extra high-catechin GT1 (458 mg catechins, 104 mg caffeine/day), two servings of a high-catechin GT2 (468 mg catechins, 126 mg caffeine/day) or two servings of the extra high-catechin GT3 (886 mg catechins, 198 mg caffeine/day) for 90 days. Data were collected at 0, 30, 60, and 90 days. We observed a decrease in estimated intra-abdominal fat (IAF) area of 5.6 cm<sup>2</sup> in the GT3 group. In addition, we found decreases of 1.9 cm in waist circumference and 1.2 kg body weight in the GT3 group vs. C (<em>P</em> &lt; 0.05). We also observed reductions in total body fat (GT2, 0.7 kg, <em>P</em> &lt; 0.05) and body fat % (GT1, 0.6%, <em>P</em> &lt; 0.05). We conclude that consumption of two servings of an extra high-catechin GT leads to improvements in body composition and reduces abdominal fatness in moderately overweight Chinese subjects.</span></p>
<p class="MsoNormal" style="line-height: normal; margin: 0in 0in 10pt; background: white; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"><span style="font-family: " lang="EN"><em>&#8220;What an interesting study!  The moral of the story here is that ingesting 400-800 mg of EGCG per day results in a reduction of weight and waist.  An additional insight here is that majority of individuals who lose weight (more than 10 lbs) will gain it all back in 5 years.  The secret is to have a long term contingency plan that will help you keep the weight off.  My recommendation is to use one <a href="http://www.grenx.com/ProductPage.aspx?ItemID=148" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">Peach Cream</a>, one <a href="http://www.grenx.com/ProductPage.aspx?ItemID=111" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">Muscle Pump </a>and a <a href="http://www.grenx.com/ProductPage.aspx?ItemID=39" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">Beauty Tea </a>each day!&#8221; &#8211; Josh Smith</em></span></p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/09/green-tea-egcg-and-weight-loss/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Protecting your skin: an inside out approach with EGCG</title>
		<link>http://www.greenteahp.info/2009/09/protecting-your-skin-an-inside-out-approach-with-egcg/</link>
		<comments>http://www.greenteahp.info/2009/09/protecting-your-skin-an-inside-out-approach-with-egcg/#comments</comments>
		<pubDate>Wed, 23 Sep 2009 19:45:51 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[beauty tea]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[green tea and skin]]></category>
		<category><![CDATA[skin]]></category>
		<category><![CDATA[skin cancer]]></category>
		<category><![CDATA[skin protection]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=40</guid>
		<description><![CDATA[ 
Skin photoprotection by green tea: antioxidant and immunomodulatory effects.
Curr Drug Targets Immune Endocr Metabol Disord. 2003 Sep;3(3):234-42.Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Because of a characteristic aroma and health benefits, green tea is consumed worldwide as a popular beverage. The epicatechin derivatives, commonly called polyphenols, present in green tea possess [...]]]></description>
			<content:encoded><![CDATA[<h2> <span title="Current drug targets. Immune, endocrine and metabolic disorders."></p>
<p class="MsoNormal" style="text-align: left;"><span style="text-decoration: underline;"><span style="font-family: "><span style="font-size: small;">Skin photoprotection by green tea: antioxidant and immunomodulatory effects.</span></span></span></p>
<p class="MsoNormal" style="text-align: left;"><span style="font-size: 10pt; font-family: "><a href="javascript:AL_get(this,%20'jour',%20'Curr%20Drug%20Targets%20Immune%20Endocr%20Metabol%20Disord.');"><span style="color: windowtext;">Curr Drug Targets Immune Endocr Metabol Disord.</span></a> 2003 Sep;3(3):234-42.</span><span style="font-size: 10pt; color: #000000;">Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</span></p>
<p class="MsoNormal" style="text-align: left;"><span style="color: #000000;"><span style="font-size: small;">Because of a characteristic aroma and health benefits, green tea is consumed worldwide as a popular beverage. The epicatechin derivatives, commonly called polyphenols, present in green tea possess antioxidant, anti-inflammatory and anti-carcinogenic properties. The major and most highly chemopreventive constituent in green tea responsible for the biochemical or pharmacological effects is (-)-epigallocatechin-3-gallate (EGCG). Epidemiological, clinical and biological studies have implicated that solar ultraviolet (UV) light is a complete carcinogen and repeated exposure can lead to the development of various skin disorders including melanoma and nonmelanoma skin cancers. We and others have shown that topical treatment or oral consumption of green tea polyphenols (GTP) inhibit chemical carcinogen- or UV radiation-induced skin carcinogenesis in different laboratory animal models. Topical treatment of GTP and EGCG or oral consumption of GTP resulted in prevention of UVB-induced inflammatory responses, immunosuppression and oxidative stress, which are the biomarkers of several skin disease states. Topical application of GTP and EGCG prior to exposure of UVB protects against UVB-induced local as well as systemic immune suppression in laboratory animals, which was associated with the inhibition of UVB-induced infiltration of inflammatory leukocytes. Prevention of UVB-induced suppression of immune responses by EGCG was also associated with the reduction in immunosuppressive cytokine interleukin (IL)-10 production at UV irradiated skin and draining lymph nodes, whereas IL-12 production was significantly enhanced in draining lymph nodes. Antioxidant and anti-inflammatory effects of green tea were also observed in human skin. Treatment of EGCG to human skin resulted in the inhibition of UVB-induced erythema, oxidative stress and infiltration of inflammatory leukocytes. We also showed that treatment of GTP to human skin prevents UVB-induced cyclobutane pyrimidine dimers formation, which are considered to be mediators of UVB-induced immune suppression and skin cancer induction. The in vitro and in vivo animal and human studies suggest that green tea polyphenols are photoprotective in nature, and can be used as pharmacological agents for the prevention of solar UVB light-induced skin disorders including photoaging, melanoma and nonmelanoma skin cancers after more clinical trials in humans.</span></span></p>
<p class="MsoNormal" style="text-align: left;"><span><span style="font-size: small;"><em>The conclusion of this study suggests that taking a bath in green tea may in fact act in the prevention of different skin disorders, I&#8217;m adding the taking a bath in green tea part, but you get the idea.  The best way is actually consuming </em></span><a href="http://www.grenx.com/ProductPage.aspx?ItemID=39" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');"><span style="color: #0000ff;"><span style="font-size: small;"><em>The Beauty Tea </em></span></span></a><span style="font-size: small;"><em>by </em></span><a href="http://www.grenx.com/RetailProductList.aspx" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');"><span style="color: #0000ff;"><span style="font-size: small;"><em>GreenTeaHP</em></span></span></a><span style="font-size: small;"><em>!  Consuming one pixie daily will give you the benefits you need from the inside out! &#8211; Josh Smith</em></span></span></p>
<p> </p>
<p> </p>
<p></span></h2>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/09/protecting-your-skin-an-inside-out-approach-with-egcg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EGCG and Pancreatic Cancer</title>
		<link>http://www.greenteahp.info/2009/09/egcg-and-pancreatic-cancer/</link>
		<comments>http://www.greenteahp.info/2009/09/egcg-and-pancreatic-cancer/#comments</comments>
		<pubDate>Mon, 21 Sep 2009 19:53:11 +0000</pubDate>
		<dc:creator>JoshSmith</dc:creator>
				<category><![CDATA[Distributors]]></category>
		<category><![CDATA[Health Benefits]]></category>
		<category><![CDATA[apoptosis]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer management]]></category>
		<category><![CDATA[cancer treatment]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[pancreas]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=39</guid>
		<description><![CDATA[Front Biosci. 2008 Jan 1;13:440-52
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.Shankar S, Ganapathy S, Hingorani SR, Srivastava RK.Department of Biochemistry, University of Texas Health Science Center at Tyler, Tyler, Texas 75703, USA.
We have shown that epigallocatechin-3-gallate (EGCG), a polyphenolic compound from green tea, inhibits growth and induces apoptosis in human pancreatic cancer [...]]]></description>
			<content:encoded><![CDATA[<h2><span title="Frontiers in bioscience : a journal and virtual library."><a href="javascript:AL_get(this, 'jour', 'Front Biosci.');">Front Biosci.</a></span> 2008 Jan 1;13:440-52</h2>
<h2>EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.<a href="http://www.greenteahp.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Shankar%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus" >Shankar S</a>, <a href="http://www.greenteahp.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ganapathy%20S%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus" >Ganapathy S</a>, <a href="http://www.greenteahp.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Hingorani%20SR%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus" >Hingorani SR</a>, <a href="http://www.greenteahp.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Srivastava%20RK%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus" >Srivastava RK</a>.Department of Biochemistry, University of Texas Health Science Center at Tyler, Tyler, Texas 75703, USA.</h2>
<p class="abstract">We have shown that epigallocatechin-3-gallate (EGCG), a polyphenolic compound from <a href="http://www.grenx.com/RetailProductList.aspx" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">green tea</a>, inhibits growth and induces apoptosis in human pancreatic cancer cells. However, the preclinical potential of EGCG in a suitable mouse model has not been examined. In this study, we examined the molecular mechanisms by which EGCG inhibited growth, invasion, metastasis and angiogenesis of human pancreatic cancer cells in a xenograft model system. EGCG inhibited viability, capillary tube formation and migration of HUVEC, and these effects were further enhanced in the presence of an ERK inhibitor. In vivo, AsPC-1 xenografted tumors treated with EGCG showed significant reduction in volume, proliferation (Ki-67 and PCNA staining), angiogenesis (vWF, VEGF and CD31) and metastasis (MMP-2, MMP-7, MMP-9 and MMP-12) and induction in apoptosis (TUNEL), caspase-3 activity and growth arrest (p21/WAF1). EGCG also inhibited circulating endothelial growth factor receptor 2 (VEGF-R2) positive endothelial cells derived from xenografted mice. Tumor samples from EGCG treated mice showed significantly reduced ERK activity, and enhanced p38 and JNK activities. Overall, our data suggest that <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">EGCG </a>inhibits pancreatic cancer growth, invasion, metastasis and angiogenesis, and thus could be used for the management of pancreatic cancer prevention and treatment.</p>
<p class="abstract"><em>&#8220;The findings of this study are a huge step in the direction of a lifestyle interventions that can be used on an individual basis for specific chronic diseases.  After reading this the evidence continues to compile for consuming wholesome EGCG&#8217;s on a daily basis.  I get mine from <a href="http://www.grenx.com/ProductPage.aspx?ItemID=2" onclick="javascript:pageTracker._trackPageview('/outbound/article/www.grenx.com');">GreenTeaHP</a>! &#8221; &#8211; Josh Smith </em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/09/egcg-and-pancreatic-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GreenTea HP and nutrient decline from fruits/veggies</title>
		<link>http://www.greenteahp.info/2009/08/greentea-hp-and-nutrient-decline-from-fruitsveggies/</link>
		<comments>http://www.greenteahp.info/2009/08/greentea-hp-and-nutrient-decline-from-fruitsveggies/#comments</comments>
		<pubDate>Wed, 26 Aug 2009 19:53:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[black tea]]></category>
		<category><![CDATA[egcg]]></category>
		<category><![CDATA[fruits]]></category>
		<category><![CDATA[green tea]]></category>
		<category><![CDATA[greentea hp]]></category>
		<category><![CDATA[greenteahp]]></category>
		<category><![CDATA[home business]]></category>
		<category><![CDATA[mlm]]></category>
		<category><![CDATA[muscle pump]]></category>
		<category><![CDATA[network markeing]]></category>
		<category><![CDATA[pink]]></category>
		<category><![CDATA[tea]]></category>
		<category><![CDATA[veggies]]></category>

		<guid isPermaLink="false">http://www.greenteahp.info/?p=31</guid>
		<description><![CDATA[
Published in HortScience 44: 15-19 (2009)American Society for Horticultural Science
 

Declining Fruit and Vegetable Nutrient Composition: What Is the Evidence?


Donald R. Davis Biochemical Institute, The University of Texas, Austin, TX 78712; and Bio-Communications Research Institute, 3100 North Hillside Avenue, Wichita, KS 67219 

&#8220;Three kinds of evidence point toward declines of some nutrients in fruits and vegetables [...]]]></description>
			<content:encoded><![CDATA[<p><strong></strong></p>
<p><strong></strong><span>Published in HortScience 44: 15-19 (2009)</span><span style="text-decoration: underline;"><span><span>American Society for Horticultural Science</span></span></span></p>
<p> </p>
<p><strong></strong></p>
<p><strong><span>Declining Fruit and Vegetable Nutrient Composition: What Is the Evidence?<br />
</span></strong></p>
<p><strong></strong></p>
<p><strong>Donald R. Davis </strong><em>Biochemical Institute, The University of Texas, Austin, TX 78712; and Bio-Communications Research Institute, 3100 North Hillside Avenue, Wichita, KS 67219 </em></p>
<p><em></em></p>
<p>&#8220;Three kinds of evidence point toward declines of some nutrients in fruits and vegetables available in the United States and the United Kingdom: 1) early studies of fertilization found inverse relationships between crop yield and mineral concentrations. The widely cited &#8220;dilution effect&#8221;; 2) three recent studies of historical food composition data found apparent median declines of 5% to 40% or more in some minerals in groups of vegetables and perhaps fruits; one study also evaluated vitamins and protein with similar results; and 3) recent side-by-side plantings of low- and high-yield cultivars of broccoli and grains found consistently negative correlations between yield and concentrations of minerals and protein, a newly recognized genetic dilution effect. Studies of historical food composition data are inherently limited, but the other methods can focus on single crops of any kind, can include any nutrient of interest, and can be carefully controlled. They can also test proposed methods to minimize or overcome the diluting effects of yield whether by environmental means or by plant breeding.&#8221;</p>
<p><strong>In other words the 20% percent of the population that actually eats what they&#8217;re supposed to, now will need to eat more to offset the decline in nutrient content. Which adds calories&#8230;the solution&#8230;GreenTea HP! Concentrated antioxidants with minerals to compensate for the decrease in our food!  Josh Smith</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.greenteahp.info/2009/08/greentea-hp-and-nutrient-decline-from-fruitsveggies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
